The role of topical immune response modifiers in skin cancer (Q36595124)

15 August 2017

1 reference

title

The role of topical immune response modifiers in skin cancer (English)

1 reference

15 August 2017

Courtney Woodmansee

1

1 reference

15 August 2017

Jessica Pillow

series ordinal

2

1 reference

15 August 2017

Robert B Skinner

series ordinal

3

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

66

1 reference

15 August 2017

1657-1664

1 reference

15 August 2017

13

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666130-00001

15 August 2017

0 references

cites work

Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666130-00001

Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod

21 January 2018

1 reference

12 December 2020

Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle

1 reference

12 December 2020

Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults

1 reference

12 December 2020

Immunotherapy of basal cell carcinoma: evolving approaches

1 reference

12 December 2020

Imiquimod 5% cream in the treatment of Bowen's disease

1 reference

12 December 2020

Treatment of lentigo maligna with topical imiquimod.

1 reference

12 December 2020

Topical 5% imiquimod for the therapy of actinic cheilitis

1 reference

12 December 2020

Topical immunomodulation in dermatology: potential of toll-like receptor agonists

1 reference

12 December 2020

Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod

1 reference

12 December 2020

Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports

1 reference

12 December 2020

Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial

1 reference

12 December 2020

Topical imiquimod treatment of a cutaneous melanoma metastasis

1 reference

12 December 2020

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens

1 reference

12 December 2020

Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease

1 reference

12 December 2020

A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses

1 reference

12 December 2020

Nonmelanoma cancers of the skin

1 reference

12 December 2020

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

1 reference

12 December 2020

Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream.

1 reference

12 December 2020

Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy

1 reference

12 December 2020

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

1 reference

12 December 2020

Successful treatment of extramammary Paget's disease with imiquimod.

1 reference

12 December 2020

Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report

1 reference

12 December 2020

Topical imiquimod in the treatment of metastatic melanoma to skin

1 reference

12 December 2020

Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study

1 reference

12 December 2020

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod

1 reference

12 December 2020

Successful topical immunotherapy of bowenoid papulosis with imiquimod

1 reference

12 December 2020

Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream

1 reference

12 December 2020

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

1 reference

12 December 2020

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

1 reference

12 December 2020

Imiquimod: a novel treatment for lentigo maligna

1 reference

12 December 2020

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

1 reference

12 December 2020

10.2165/00003495-200666130-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference